These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 22818111)
41. Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000). Kim BN; Kim NJ; Kim MN; Kim YS; Woo JH; Ryu J Scand J Infect Dis; 2003; 35(2):98-103. PubMed ID: 12693558 [TBL] [Abstract][Full Text] [Related]
42. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae. Berçot B; Poirel L; Dortet L; Nordmann P J Antimicrob Chemother; 2011 Oct; 66(10):2295-7. PubMed ID: 21807739 [TBL] [Abstract][Full Text] [Related]
43. Intravenous colistin administration in neonates. Jajoo M; Kumar V; Jain M; Kumari S; Manchanda V Pediatr Infect Dis J; 2011 Mar; 30(3):218-21. PubMed ID: 21245777 [TBL] [Abstract][Full Text] [Related]
44. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Hartzell JD; Neff R; Ake J; Howard R; Olson S; Paolino K; Vishnepolsky M; Weintrob A; Wortmann G Clin Infect Dis; 2009 Jun; 48(12):1724-8. PubMed ID: 19438394 [TBL] [Abstract][Full Text] [Related]
45. Colistin pharmacokinetics: the fog is lifting. Couet W; Grégoire N; Marchand S; Mimoz O Clin Microbiol Infect; 2012 Jan; 18(1):30-9. PubMed ID: 21988234 [TBL] [Abstract][Full Text] [Related]
46. Meningitis due to Providencia stuartii. Sipahi OR; Bardak-Ozcem S; Ozgiray E; Aydemir S; Yurtseven T; Yamazhan T; Tasbakan M; Ulusoy S J Clin Microbiol; 2010 Dec; 48(12):4667-8. PubMed ID: 20980575 [TBL] [Abstract][Full Text] [Related]
47. Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital. Samonis G; Korbila IP; Maraki S; Michailidou I; Vardakas KZ; Kofteridis D; Dimopoulou D; Gkogkozotou VK; Falagas ME Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1505-10. PubMed ID: 24798249 [TBL] [Abstract][Full Text] [Related]
48. Nephrotoxicity associated with the use of intravenous colistin. Santamaría C; Mykietiuk A; Temporiti E; Stryjewski ME; Herrera F; Bonvehi P Scand J Infect Dis; 2009; 41(10):767-9. PubMed ID: 19685371 [TBL] [Abstract][Full Text] [Related]
49. Colistin: new lessons on an old antibiotic. Yahav D; Farbman L; Leibovici L; Paul M Clin Microbiol Infect; 2012 Jan; 18(1):18-29. PubMed ID: 22168320 [TBL] [Abstract][Full Text] [Related]
50. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967 [TBL] [Abstract][Full Text] [Related]
51. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial. DiPersio JR; Dowzicky MJ Int J Antimicrob Agents; 2007 May; 29(5):518-27. PubMed ID: 17376657 [TBL] [Abstract][Full Text] [Related]
52. Eradication of multidrug-resistant Acinetobacter baumannii from the respiratory tract with inhaled colistin methanesulfonate: a matched case-control study. Kuo SC; Lee YT; Yang SP; Chen CP; Chen TL; Hsieh SL; Siu LK; Fung CP Clin Microbiol Infect; 2012 Sep; 18(9):870-6. PubMed ID: 21999321 [TBL] [Abstract][Full Text] [Related]
53. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens. Poulakou G; Kontopidou FV; Paramythiotou E; Kompoti M; Katsiari M; Mainas E; Nicolaou C; Yphantis D; Antoniadou A; Trikka-Graphakos E; Roussou Z; Clouva P; Maguina N; Kanellakopoulou K; Armaganidis A; Giamarellou H J Infect; 2009 Apr; 58(4):273-84. PubMed ID: 19344841 [TBL] [Abstract][Full Text] [Related]
54. Septicemia in an Indian Rhesus Macaque (Macaca mulatta) associated with Providencia stuartii. Liu DX; Didier PJ; Plauche G; Pahar B J Med Primatol; 2016 Dec; 45(6):330-332. PubMed ID: 27466784 [TBL] [Abstract][Full Text] [Related]
55. Establishing the role of tigecycline in an era of antimicrobial resistance. Schafer JJ; Goff DA Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395 [TBL] [Abstract][Full Text] [Related]
56. Colistin in combination with rifampin and imipenem for treating a blaVIM-1 metallo-beta-lactamase-producing Enterobacter cloacae disseminated infection in a liver transplant patient. Tascini C; Urbani L; Biancofiore G; Rossolini GM; Leonildi A; Gemignani G; Bindi ML; Mugnaioli C; Filipponi F; Menichetti F Minerva Anestesiol; 2008; 74(1-2):47-9. PubMed ID: 18059255 [TBL] [Abstract][Full Text] [Related]
57. In vitro activities of 'new' and 'conventional' antibiotics against multi-drug resistant Gram negative bacteria from patients in the intensive care unit. Ratnam I; Franklin C; Spelman DW Pathology; 2007 Dec; 39(6):586-8. PubMed ID: 18027263 [TBL] [Abstract][Full Text] [Related]
58. Hypersensitivity pneumonitis due to high-dose colistin aerosol therapy. Leong KW; Ong S; Chee HL; Lee W; Kwa AL Int J Infect Dis; 2010 Nov; 14(11):e1018-9. PubMed ID: 20947404 [TBL] [Abstract][Full Text] [Related]
59. First detection of TEM-116 extended-spectrum β-lactamase in a Providencia stuartii isolate from a Tunisian hospital. Lahlaoui H; Dahmen S; Moussa MB; Omrane B Indian J Med Microbiol; 2011; 29(3):258-61. PubMed ID: 21860106 [TBL] [Abstract][Full Text] [Related]
60. [Shedding light on the use of colistin: still gaps to be filled]. Luque S; Grau S; Berenguer N; Horcajada JP; Sorlí L; Montero MM; Salas E Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):287-96. PubMed ID: 21440335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]